Re-Assessing EBS CEO Kramer's Recent Planned Sales
Emergent BioSolutions Inc. (EBS) CEO and President Robert Kramer has been in the news recently due to the company's issues related to the production of the Coronavirus vaccine. In light of recent developments, we re-assess Kramer's planned selling from earlier this year.
Have Insiders That Bought the Dip in March Sold Their Shares?
In early August, The Washington Service took a look at the claims being made by several outlets that insiders, who had bought into the market during its dip in March, were bailing out of their positions. Now that the short swing window has elapsed, did those same insiders dump their positions?